Everyday Health: ...and Fewer Cases Diagnosed Earlier. New study results suggests that the cost of more conservative screening for prostate cancer may be more men diagnosed at more advanced, difficult to treat stages.
The rate of advanced prostate cancer rose in U.S. men 50 and older in the five years following a U.S. Preventive Services Task Force (USPSTF) recommendation against prostate specific antigen (PSA) screening for men of all ages, according to a study published May 20, 2020, in the Journal of the National Cancer Institute.
The study also found that the incidence of early disease that has not spread beyond the prostate gland decreased during the same period. The implication of the study is that a decline in screening has meant that cancers are caught at a later stage, according to the authors. READ MORE.
(Source: Everyday Health, 05/21/2020 )